Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 34.08% Profit: A Success Story for QuantWave

May 30, 2025
REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) recently achieved a price target forecast set by QuantWave, resulting in a remarkable profit of 34.08% for investors. The forecast signal was issued on March 10, 2025, with a price of 743.73 $. The predicted direction was short, and on May 30, 2025, the stock hit the target price of 490.28 $, delivering significant gains to those who followed the forecast.

This success highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The detailed market analysis provided by the platform allowed investors to make informed decisions and capitalize on market opportunities. Factors contributing to the stock movement of REGENERON PHARMACEUTICALS, INC. may include industry trends, company performance, and macroeconomic indicators.

QuantWave is an automated forecasting platform that offers predictions for a wide range of stocks, presenting users with opportunities for potential profits. For investors looking to deepen their understanding of the investment strategy behind QuantWave, QuantSchool provides comprehensive educational resources. QuantSchool outlines the key principles for generating consistent income using the QuantWave forecasting system, empowering investors to make sound investment decisions based on data-driven insights.
If you want to leave a comment, then you need Login or Register





Other data for REGN

Related data

REGNSeptember 5, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) has been making waves in the stock market recently, with Evercore ISI maintaining a buy rating and a price target of 750....


REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....


REGNJune 27, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target  ~1 min.

Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on December 13, 2024, predicted a short direction with a price of 728.18 $. On June 5, 2025, the stock reached the target price of 482....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the forecast price target set by QuantWave, resulting in a profit of 32.0%. The forecast signal was issued on December 31, 2024, with a price of $709....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. (REGN) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 27.18%....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25%  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025. The forecast indicated a short direction, with the stock price at $657....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. (ticker: REGN) has successfully achieved the price target forecast set by QuantWave, realizing a profit of 27.18%....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with a Profit of 30.6%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit of 30.6% for investors who followed the short signal....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast on QuantWave with 16.34% Profit  ~2 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. with a price target forecast of 571.74 $, signaling a potential 16....


REGNOctober 31, 2024REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Price Target with Profit of 17.54%  ~2 min.

REGENERON PHARMACEUTICALS, INC. (stock ticker: REGN) recently saw its stock price hit the forecast target set by QuantWave, a leading automated forecasting platform....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 34.08% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock successfully reached the price target forecast set by QuantWave on May 30, 2025. The forecast signal was initiated on March 10, 2025, with a price of 742.6 $....


REGNOctober 31, 2024Regeneron Pharmaceuticals, Inc. Hits QuantWave's Forecast Price Target with 16.62% Profit  ~1 min.

Regeneron Pharmaceuticals, Inc. recently achieved the price target forecast set by QuantWave, marking a 16.62% profit for investors....